Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anika Therapeutics (ANIK) Work In Process: 2011-2017

Historic Work In Process for Anika Therapeutics (ANIK) over the last 7 years, with Dec 2017 value amounting to $6.1 million.

  • Anika Therapeutics' Work In Process fell 9.38% to $5.9 million in Q3 2018 from the same period last year, while for Sep 2018 it was $5.9 million, marking a year-over-year decrease of 9.38%. This contributed to the annual value of $6.1 million for FY2017, which is 9.05% up from last year.
  • As of FY2017, Anika Therapeutics' Work In Process stood at $6.1 million, which was up 9.05% from $5.6 million recorded in FY2016.
  • In the past 5 years, Anika Therapeutics' Work In Process registered a high of $6.1 million during FY2017, and its lowest value of $2.3 million during FY2013.
  • In the last 3 years, Anika Therapeutics' Work In Process had a median value of $5.7 million in 2015 and averaged $5.8 million.
  • In the last 5 years, Anika Therapeutics' Work In Process spiked by 197.05% in 2013 and then decreased by 1.71% in 2016.
  • Yearly analysis of 5 years shows Anika Therapeutics' Work In Process stood at $2.3 million in 2013, then spiked by 31.75% to $3.0 million in 2014, then soared by 85.99% to $5.7 million in 2015, then dropped by 1.71% to $5.6 million in 2016, then climbed by 9.05% to $6.1 million in 2017.